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Abstract
Background: The method used to delineate the boundary of the right ventricle (RV), relative to the trabeculations and
papillary muscles in cardiovascular magnetic resonance (CMR) ventricular volume analysis, may matter more when these
structures are hypertrophied than in individuals with normal cardiovascular anatomy. This study aimed to compare two
methods of cavity delineation in patients with systemic RV.
Methods: Twenty-nine patients (mean age 34.7 ± 12.4 years) with a systemic RV (12 with congenitally corrected
transposition of the great arteries (ccTGA) and 17 with atrially switched (TGA) underwent CMR. We compared
measurements of systemic RV volumes and function using two analysis protocols. The RV trabeculations and papillary
muscles were either included in the calculated blood volume, the boundary drawn immediately within the apparently
compacted myocardial layer, or they were manually outlined and excluded. RV stroke volume (SV) calculated using each
method was compared with corresponding left ventricular (LV) SV. Additionally, we compared the differences in analysis
time, and in intra- and inter-observer variability between the two methods. Paired samples t-test was used to test for
differences in volumes, function and analysis time between the two methods. Differences in intra- and inter-observer
reproducibility were tested using an extension of the Bland-Altman method.
Results: The inclusion of trabeculations and papillary muscles in the ventricular volume resulted in higher values for
systemic RV end diastolic volume (mean difference 28.7 ± 10.6 ml, p < 0.001) and for end systolic volume (mean
difference 31.0 ± 11.5 ml, p < 0.001). Values for ejection fraction were significantly lower (mean difference -7.4 ± 3.9%,
p < 0.001) if structures were included. LV SV did not differ significantly from RV SV for both analysis methods (p = NS).
Including structures resulted in shorter analysis time (p < 0.001), and showed better inter-observer reproducibility for
ejection fraction (p < 0.01).
Conclusion: The choice of method for systemic RV cavity delineation significantly affected volume measurements, given
the CMR acquisition and analysis systems used. We recommend delineation outside the trabeculations for routine clinical
measurements of systemic RV volumes as this approach took less time and gave more reproducible measurements.
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The number of adult patients with a congenital heart
defect is steadily increasing with the constant improve-
ment of cardiac surgery. A substantial portion of these
patients has a morphologic right ventricle (RV) support-
ing the systemic circulation (e.g. patients with a congeni-
tally corrected transposition of the great arteries (ccTGA)
or a complete transposition of the great arteries (TGA)
after an atrial switch operation). Medium term survival in
patients with a systemic RV is relatively good. However,
long-term outcome is unknown, and morbidity is worri-
some, with RV dysfunction, tricuspid valve regurgitation,
and arrhythmias being the main constituents. [1-4]
Assessment of ventricular function is of particular impor-
tance, as European guidelines consider it an important
part of preoperative assessment, (peri-operative) manage-
ment and follow-up of patients with any congenital heart
defect. [5] Moreover, decisions on the timing of surgical
intervention in patients with a systemic RV are frequently
based on RV function. [6,7] Therefore, the importance of
having an accurate and reproducible diagnostic tool for
the evaluation and follow-up of systemic RV volumes and
function is evident.
For the assessment of subpulmonary and systemic RV vol-
umes and function Cardiovascular Magnetic Resonance
(CMR) is considered the gold standard. [8-15] In individ-
uals with normal cardiac anatomy the influence of trabec-
ulations and papillary muscles on measured ventricular
volumes seems of marginal importance. The differences in
measured ventricular volumes and function when these
structures are included in the ventricular cavity, compared
to when structures are excluded, are small and unlikely to
influence clinical decision making.[16,17] However,
patients with a systemic RV pose a challenge, as the
method of delineating the cavity relative to the hypertro-
phied trabeculations and papillary muscles could affect
RV volume and function measurements. [18]
To our knowledge, no study has ever addressed the issue
of CMR analysis methods in this patient group. Aim of the
present study was to evaluate the impact of trabeculations
and papillary muscles on systemic RV measurements, by
comparing a CMR analysis method in which trabecula-
tions and papillary muscles were included in the RV vol-
ume to an analysis method in which these structures were
excluded from RV volume (figure 1). Additionally, differ-
ences in analysis time and intra- and inter-observer repro-
ducibility between analysis methods were evaluated.
Methods
Study population
A total of 29 adult patients (69% male, mean age 34.7 ±
12.4 years) with a systemic RV underwent CMR for the
evaluation of RV volumes and function. Twelve patients
had a ccTGA, 17 patients an atrially switched TGA. The
Institutional Review Boards of all three participating terti-
ary referral centers approved the study protocol. Written
informed consent was obtained from all patients prior to
participation in the study.
Image acquisition
Image acquisition was performed by CMR, using a 1,5
Tesla scanner (Siemens Avanto, Erlangen, Germany),
using standardly available sequences to assess ventricular
Four chamber image from a multi-phase steady-state free precision sequence of the highly trabeculized systemic RV in a patient with an atrially switched TGA (a) and in a patien  with a congenitally corrected TGA (b)igure 1
Four chamber image from a multi-phase steady-state free precision sequence of the highly trabeculized systemic RV in a patient 
with an atrially switched TGA (a) and in a patient with a congenitally corrected TGA (b).
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heart, a multi-phase steady-state free precession sequence
(SSFP) with retrospective electrocardiographic triggering
was applied to visualize two-chamber, three-chamber and
four-chamber views. Guided by these views, a multislice
and multiphase SSFP sequence was applied perpendicular
to the ventricular septum, encompassing the total heart.
These sequences were individually adjusted to acquire
short axis slices with optimal spatial and temporal resolu-
tion. Typical parameters were: flip angle: 50–70 degrees;
repetition time: 3–4 msec; echo time: 1–2 msec; temporal
resolution: 40 msec, 1–2 × 1–2 mm/pixel in-plane spatial
resolution, 8 mm slice thickness, and 1 mm interslice gap.
This resulted in 9 to 15 slices to cover the whole heart.
CMR images were acquired during repeated end-expira-
tory breath holds.
Image analyses
For CMR image analysis two independent observers (MW,
FB) used MASS Analytical Software System (Medis, Lei-
den, the Netherlands). Cine loops were used to choose
end diastole (ED) and end systole (ES). ED was defined as
the phase with the largest RV (and left ventricular (LV))
area and ES as the phase with the smallest RV (and LV)
area. The slices at the base of the heart were considered to
be in the ventricle if the blood was at least half surrounded
by ventricular myocardium. Cine loop movies in phase
and slice were used in case the distinction between the
ventricles, atria and great vessels was unclear. Moreover,
four-chamber views in phase with the short axis views
were available. Tracing was performed manually on each
ED and ES short-axis view.
The sums of the traced contours in ED en ES were used to
calculate ED volume (EDV) and ES volume (ESV) using a
disc summation technique. EDV and ESV were used to cal-
culate Stroke Volume (SV) and Ejection Fraction (EF). SV
was defined as EDV - ESV, and EF as [(EDV - ESV)/EDV] ×
100%.
CMR analysis methods
All contours were traced twice, using two different tracing
methods. Both the systemic RV, and the subpulmonary LV
were subjected to both analysis methods. Method A: Con-
tour tracing was first performed including the papillary
muscles and trabeculations in the ventricular cavity, by
tracing immediately within the apparently compact layer
of the myocardium. A continuous movie display of the
slice being evaluated was used to enhance differentiation
between trabeculations, papillary muscles and the ven-
tricular free wall. Although the exclusion of complex RV
trabeculations and papillary muscles is relatively easy in
ED, optimal differentiation is especially important in the
ES phases as trabeculations and papillary muscles com-
press and fold during systole making the end-systolc bor-
der of trabeculations and blood volume less distinct. This
method resulted in smooth contours (figure 2, method
A). Method B: Contour tracing was then performed exclud-
ing the papillary muscles and trabeculations from the ven-
tricular volume. This was done by tracing around these
structures if attached to the ventricular wall and by tracing
them separately if not attached to the ventricular wall.
This resulted in irregular endocardial contours (figure 2,
method B).
To ensure that found differences would only be due to the
impact of papillary muscles and trabeculations both anal-
ysis methods were performed on the same ED and ES
phases, and the same slices for each patient. Duration of
RV volume and function analysis was recorded for both
analysis methods.
Statistical methods
For statistical analyses SPSS 12.0.1 (SPSS Inc., Chicago,
Illinois) for Windows was used. P values < 0.05 were con-
sidered statistically significant. The shift between the two
tracing methods was compared with the two-tailed paired
t test, calculating mean, standard deviation and statistical
significance of the differences. The agreement between the
two tracing methods was assessed and visualized with the
method and plots as described by Bland and Altman. [19]
Agreement between RV SV and LV SV for both analysis
methods was assessed using a two-tailed paired t test.
Intra- and inter-observer reproducibility of the two analy-
sis methods was determined from the mean value and the
differences between the two measurements. The coeffi-
cient of variability was calculated as the standard devia-
tion of the difference of the paired measurements divided
by the mean of the average of the paired measurements,
and expressed as a percentage. An extension of the Bland-
Altman method was used to assess the statistical signifi-
cance of differences in intra- and interobserver reproduci-
bility between the two analysis methods. A log
transformation of the squared differences between the
two measurements was performed. If the squared differ-
ence was zero, we replaced the value by the next smallest
value multiplied by 0.5. A two-tailed paired t test of the
logged squared differences was performed thereafter.[16]
Results
Differences in measured volumes and function (Additional 
file 1)
Including trabeculations and papillary muscles in the sys-
temic RV volume (Method A) resulted in significantly
higher outcome measures for EDV with a mean difference
of 28.7 ml (95% CI 24.7 – 32.7, p < 0.001), and for ESV
with a mean difference of 31.0 ml (95% CI 26.7 – 35.4, p
< 0.001), compared to when structures were excluded
from the ventricular volume (Method B). This resulted inPage 3 of 8
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mean difference of 7.4% (95% CI -8.9 – -5.9, p < 0.001).
No significant changes were found for SV and CO. Bland-
Altman plots were used to visualize the systematic differ-
ences between Method A and B (figure 3).
We found no statistically significant differences between
RV SV and LV SV, when trabeculations and papillary mus-
cles were included in the RV and LV volumes (75.5 ± 18.5
ml vs. 71.1 ± 23.9 ml; p = NS), neither when structures
were excluded from the RV and LV volumes (77.8 ± 18.4
ml vs. 69.3 ± 22.3 ml, p = NS).
Analysis time was significantly shorter when using
Method A (20 ± 3 min) compared to Method B (26 ± 4
min); p < 0.001.
Assessment of systemic right ventricular volumes using two different analysis protocolsFigure 2
Assessment of systemic right ventricular volumes using two different analysis protocols. Short axis view from a 
multi-phase steady-state free precision sequence in end systole (left) and end diastole (right) obtained in a patient with an atri-
ally switched TGA demonstrating the two analysis protocols. Method A depicts the inclusion of trabeculations and papillary 
muscles in the ventricular cavity. Method B depicts the exclusion of trabeculations and papillary muscles from the ventricular 
cavity. LV = left ventricle.
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Bland-Altman plots demonstrating the systematic differences in measured systemic right ventricular volumes and function between Method A and Me hod BFigur  3
Bland-Altman plots demonstrating the systematic differences in measured systemic right ventricular volumes 
and function between Method A and Method B. Bland-Altman plots demonstrate on the X-axis the mean value of 
Method A and Method B for each parameter (a. mean end diastolic volume; b. mean end systolic volume; c. mean stroke vol-
ume; d. mean ejection fraction), and on the Y-axis the difference between the two analysis methods for the same parameter. 
The solid line represents the mean value of the difference for each method, the dotted lines represent ± 2 SD. RVEDV = right 
ventricular end diastolic volume; RVEF = right ventricular ejection fraction; RVESV = right ventricular end systolic volume; ml = 
millilitre; SD = standard deviation; RVSV = right ventricular stroke volume. The 'A' or 'B' behind parameters indicate that val-
ues were obtained using Method A or Method B respectively.
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Analysis Method A lead to a lower coefficient of variability
for all outcome measures compared to Method B. This
indicates superior intra- and inter-observer reproducibil-
ity when including trabeculations and papillary muscles
in the ventricular volume compared to excluding these
structures. Although these differences were not found to
be statistically significant for the intra-observer measure-
ments, we found statistically significant difference in the
inter-observer reproducibility of systemic RV SV (p < 0.05)
and EF (P < 0.01), favoring the inclusion of structures in
the ventricular volume (Additional file 2).
Discussion
Including trabeculations and papillary muscles in the sys-
temic RV cavity lead to a substantially higher measured
EDV and ESV and a substantially lower calculated EF,
compared to excluding these structures from the volume
of the cavity. Although the influence of these structures on
measured ventricular volumes in individuals with normal
cardiac anatomy seems of marginal clinical impor-
tance,[16,17] their influence on systemic RV volumes was
found to be striking. Moreover, there were statistically sig-
nificant differences in analysis time and in reproducibility
between CMR analysis methods.
Although CMR is considered the most accurate diagnostic
tool for the assessment of ventricular volumes and func-
tion, [11-13,20,21], there is no consensus in the literature
on the role of trabeculations and papillary muscles. In
anatomically normal hearts, Lorenz et al. excluded trabec-
ulations and papillary muscles from the LV and the RV
cavity,[12] whereas Rominger et al. chose to include these
structures.[13] Most authors, however, refrained from
specifying the role of trabeculations and/or papillary mus-
cles in their analysis method. [22-25] Similar incomplete-
ness in methodology of CMR analysis is seen in literature
regarding patients with congenital heart defects, and with
systemic RVs in specific. Although Helbing et al. excluded
papillary muscles and the moderator band from the RV
cavity of patients with congenital heart defects,[10] and
Lidegram et al. chose to include both structures in the cav-
ity of the systemic RV,[26] most authors are less specific
on the role of these structures in their analysis
method.[11,21,27]
The influence of trabeculations and papillary muscles on
LV and RV measurements in healthy subjects and patients
with known cardiac disease (patients with congenital
heart defects were excluded) has been studied previously,
using similar analysis protocols as were used in our
study.[16,17] In anatomically normal hearts, both Sievers
et al. and Papavassiliu et al. found significant differences
in measured left and right ventricular volumes and func-
tion when comparing both CMR analysis protocols. How-
ever, both authors concluded that the observed
differences in ventricular volumes and function were too
small to influence clinical decision making, and advised
the inclusion of all structures in the ventricular cavity.
Including structures not only shortened analysis time,
Papavassiliu et al. also demonstrated superior reproduci-
bility for several outcome measures when using this anal-
ysis protocol.[16,17] Our observations in systemic RVs
differ from those of Sievers and Papavassiliu, as we found
systematic and large differences in measured systemic RV
volumes and function between the two analysis methods.
This study indicates the importance of a consistent
approach to cavity delineation relative to the trabecula-
tions and papillary muscles, to avoid misinterpretation of
measurements and erroneous clinical decision mak-
ing.[5,6]
Although the true values of systemic RV volumes and
function remain unknown, and in spite of tricuspid valve
regurgitation in some patients, we found no significant
differences between the measured RV and LV SV by either
method of analysis. However, delineation of the RV cavity
boundary outside the trabeculations and papillary mus-
cles had the advantages of shorter analysis time and better
inter-observer reproducibility. We therefore recommend
the use of this approach in routine CMR measurements of
systemic RV volumes, at least when comparable systems
for CMR acquisition and volume analysis are being used.
Study limitations
The sample size of 29 patients in two distinct clinical cat-
egories is relatively small. The methods used were not
suitable for determining which of the analysis approaches
measured systemic RV volumes more accurately. Measure-
ments of systemic RV mass were not attempted, and
remain challenging given the relative amount of trabecu-
lated RV myocardium. The slice thickness of 8 mm may
not have been optimal for clear delineation of the trabec-
ulations, making the definition of the boundaries
between trabeculations and blood, and between trabecu-
lations and apparently compact myocardium hard to
define in some cases. Moreover, as myocardial boundaries
were first defined at end diastole, detecting the corre-
sponding boundary at end systole could be difficult, due
to elimination of blood from the inter-trabecular spaces at
end systole. The important issue of inter-study reproduci-
bility was not addressed by this study. Between studies,
volume measurements might be affected by variation in
the relative positioning of the basal short axis slice, and by
variables such as the shimming of the magnet and the reli-
ability of ECG triggering.
Conclusion
We found the method of systemic RV cavity delineation to
affect the measurements of cavity volume, given the CMRPage 6 of 8
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cavity delineation inside the apparently compact myocar-
dium of the RV but outside the trabeculations and papil-
lary muscles for routine clinical measurements of systemic
RV volumes as this approach took less time and gave more
reproducible values.
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